Related Experiment Video
Updated: Feb 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
Myeongjin Jeon1,2, Daeun You1,2, Soo Youn Bae1
1Department of Surgery, Samsung Medical Center, Gangnam-gu, Seoul 06351, Korea.
Abstract:
The dimerization of EGFR and HER2 is associated with poor prognosis such as induction of tumor growth and cell invasion compared to when EGFR remains as a homodimer. However, the mechanism for events after dimerization in breast cancer models is not clear. We found that expressions of alpha-smooth muscle actin (ACTA2) and signal transducer and activator of transcription 1 (STAT1) significantly increased with transient or stable overexpression of HER2 in EGFR-positive breast cancer cells. ACTA2 and STAT1 expression was also increased in HER2-positive breast cancer patients. In contrast, ACTA2 expression was decreased by HER2 siRNA. Next, we investigated the co-relation between STAT1 and ACTA2 expression. Basal ACTA2 expression was significantly decreased by treatment with the STAT1 inhibitor fludarabine or the JAK2 inhibitor AG490. In contrast, ACTA2 expression was increased by STAT1 overexpression. Levels of ACTA2, STAT1, and HER2 were increased and relapse free survival was decreased in high-risk breast cancer patients. We also investigated the effect of ACTA2 on cell motility, which was suppressed by ACTA2 shRNA overexpression in MDA-MB231 HER2 and 4T1 mammary carcinoma cells. The number of lung metastatic nodules was significantly decreased in ACTA2 knockdown mice. Taken together, these results demonstrated that induction of ACTA2 by EGFR and HER2 dimerization was regulated through a JAK2/STAT1 signaling pathway, and aberrant ACTA2 expression accelerated the invasiveness and metastasis of breast cancer cells.
Insights
EGFR and HER2 dimerization promotes breast cancer invasion and metastasis. This process involves increased alpha-smooth muscle actin (ACTA2) expression via the JAK2/STAT1 pathway, leading to poor patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epidermal Growth Factor Receptor (EGFR) and Human Epidermal growth factor Receptor 2 (HER2) dimerization is linked to poor breast cancer prognosis, including tumor growth and invasion.
- The precise molecular mechanisms driving these outcomes post-dimerization in breast cancer remain incompletely understood.
Purpose of the Study:
- To elucidate the signaling pathways and molecular events following EGFR and HER2 dimerization in breast cancer.
- To investigate the role of alpha-smooth muscle actin (ACTA2) and signal transducer and activator of transcription 1 (STAT1) in HER2-driven breast cancer progression.
Main Methods:
- Overexpression and knockdown (siRNA, shRNA) of HER2, ACTA2, and STAT1 in EGFR-positive breast cancer cell lines (MDA-MB231 HER2, 4T1).
- Inhibition of STAT1 and JAK2 signaling pathways using fludarabine and AG490, respectively.
- Analysis of ACTA2 and STAT1 expression in patient tumor samples and correlation with relapse-free survival.
- Assessment of cell motility and lung metastasis in mouse models.
Main Results:
- HER2 overexpression significantly increased ACTA2 and STAT1 expression in breast cancer cells, while HER2 knockdown decreased ACTA2.
- ACTA2 expression was dependent on JAK2/STAT1 signaling, as indicated by inhibition with fludarabine and AG490, and enhancement with STAT1 overexpression.
- Elevated ACTA2, STAT1, and HER2 levels correlated with decreased relapse-free survival in high-risk breast cancer patients.
- ACTA2 knockdown suppressed cancer cell motility and reduced lung metastasis in vivo.
Conclusions:
- EGFR and HER2 dimerization induces ACTA2 expression through the JAK2/STAT1 signaling pathway.
- Aberrant ACTA2 expression driven by HER2 signaling accelerates breast cancer cell invasiveness and metastasis.
- Targeting the JAK2/STAT1/ACTA2 axis may offer therapeutic strategies for HER2-positive breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Receptor Tyrosine Kinases
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....

